Hyperglycemia – Pipeline Review, H2 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Hyperglycemia – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary This latest Pharmaceutical
Read morenews
Familial Amyloid Neuropathies, Pipeline Review, H2 2019: Akcea Therapeutics Inc, Pfizer Inc & Prothena Corp Plc – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Familial Amyloid Neuropathies – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary This
Read moreHeterozygous familial hypercholesterolemia, Pipeline Review, H2 2019 – Stage of Development, Drug Target, Mechanism of Action, Route of Administration & Molecule Type – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Heterozygous familial hypercholesterolemia (heFH) – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary
Read moreAcid Sphingomyelinase Deficiency Type C – Pipeline Review, H2 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C – Pipeline Review, H2 2019” drug pipelines has been added to
Read moreEpidermolysis Bullosa, Pipeline Review, H2 2019 – Almirall SA, Berg LLC, Celularity Inc, CSL Ltd & Constant Therapeutics LLC – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Epidermolysis Bullosa – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary Epidermolysis bullosa
Read moreHorizon Discovery Grants a Multi-Product Use License of its GS knockout CHO K1 Cell Line to NGM Bio
Cell line to be used to support research and development of biotherapeutics across therapeutic areas CAMBRIDGE, England–(BUSINESS WIRE)–Horizon Discovery Group
Read moreGlobal ENT Disorder Treatment Market 2020-2024 | Evolving Opportunities with AbbVie Inc. and Bayer AG | Technavio
LONDON–(BUSINESS WIRE)–#Biotechnology–Technavio has been monitoring the global ENT disorder treatment market since 2017 and the market is poised to grow
Read moreCity of Hope Opens Its First Orange County Location, Ushering in New Era of Cancer Care
World-Renowned Cancer Experts Are Speeding Lifesaving Cancer Research and Treatments to Newport Beach and the Region Key Takeaways: City of
Read moreNcardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes
LEIDEN, the Netherlands & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ncardia and BlueRock Therapeutics today announced an agreement covering process development technologies for the
Read moreREVIAN® Presents Leading Clinical Trial Results for New Hair Loss Treatment
Industry-leading 26.3 more hairs/cm2 on average after 16 weeks of 10-minutes a day LED light therapy Significant reductions in itching
Read more